Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question?·October 8, 2020
Covid19: Why aren’t you buying all doses; when will you disburse 50% of doses to states; what is the rationale for differential pricing: SC to Centre·April 30, 2021
Dynamic injunction against rogue websites streaming Cricket World Cup by Delhi High Court·September 29, 2023
Panel discussion on Intellectual Property and the Constitution: accessibility, vaccine waivers and content creation·April 16, 2022
World TB Day coincides with the Indian Patent Office rejecting J&J’s application to extend its patent on anti-tuberculosis drug Bedaquiline·March 24, 2023
Leaked Text Incorporates Stringent TRIPS Plus Elements, Global Calls for Rejection Increase·April 12, 2022
Statement by Indian Civil Society: Need for open innovation and knowledge sharing for COVID-19 healthcare through Indian IP laws·June 24, 2020
Bombay HC directs Centre to decide representation seeking ‘compulsory licenses’ to two patented anti-TB drugs·March 10, 2021
